Immunophenotypic identification and characterization of CTCL tumor cells in blood using standardized flow cytometry: a European multicenter study

Autor: S Najidh, AJ Van der Sluijs Gelling, A Cozzio, G Dobos, M Bagot, M Beylot-Barry, E Guenova, J Nicolay, M Lima, PL Ortiz-Romero, E Papadavid, R Pujol, P Quaglino, R Stadler, U Wehkamp, S Whittaker, JJM Van Dongen, J Flores Montero, J Almeida, MH Vermeer

Publikováno v: European Journal of Cancer. 173:S1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae6ad02684bade1a8dbbb4e367e3fb4d
https://doi.org/10.1016/s0959-8049(22)00548-2

Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood.

Autor: van der Pan K; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., de Bruin-Versteeg S; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Damasceno D; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Hernández-Delgado A; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., van der Sluijs-Gelling AJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., van den Bossche WBL; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.; Department of Immunology, Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, Netherlands., de Laat IF; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Díez P; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Naber BAE; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Diks AM; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Berkowska MA; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., de Mooij B; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Groenland RJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., de Bie FJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Khatri I; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Kassem S; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., de Jager AL; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Louis A; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Almeida J; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., van Gaans-van den Brink JAM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands., Barkoff AM; Institute of Biomedicine, Research Center for Infections and Immunity, University of Turku (UTU), Turku, Finland., He Q; Institute of Biomedicine, Research Center for Infections and Immunity, University of Turku (UTU), Turku, Finland., Ferwerda G; Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands., Versteegen P; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands., Berbers GAM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands., Orfao A; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., van Dongen JJM; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Teodosio C; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Sep 14; Vol. 13, pp. 935879. Date of Electronic Publication: 2022 Sep 14 (Print Publication: 2022).

Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome.

Autor: Najidh S; Department of Dermatology., Tensen CP; Department of Dermatology., van der Sluijs-Gelling AJ; Department of Immunology., Teodosio C; Department of Immunology., Cats D; Sequencing Analysis Support Core., Mei H; Sequencing Analysis Support Core., Kuipers TB; Sequencing Analysis Support Core., Out-Luijting JJ; Department of Dermatology., Zoutman WH; Department of Dermatology., van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), Cytometry Service (NUCLEUS), Department of Medicine, University of Salamanca (USAL)-Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; and.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Almeida J; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), Cytometry Service (NUCLEUS), Department of Medicine, University of Salamanca (USAL)-Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; and.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., van Dongen JJM; Department of Immunology., Vermeer MH; Department of Dermatology.

Publikováno v: Blood [Blood] 2021 Dec 16; Vol. 138 (24), pp. 2539-2554.

Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia.

Autor: Lhermitte L; Université Paris Descartes-Sorbonne Paris Cité, Institut Necker-Enfants-Malades, INSERM UMR1151, Paris, France.; Biological Hematology, AP-HP Necker-Enfants-Malades, Paris, France., Mejstrikova E; CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic., van der Sluijs-Gelling AJ; Dutch Childhood Oncology Group, The Hague, The Netherlands.; Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center, Leiden, The Netherlands., Grigore GE; Cytognos SL, Salamanca, Spain., Sedek L; Department of Microbiology and Immunology, Zabrze, Medical University of Silesia (SUM), Katowice, Poland., Bras AE; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Gaipa G; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza (MB),Italy., Sobral da Costa E; Department of Pediatrics, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Novakova M; CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic., Sonneveld E; Dutch Childhood Oncology Group, The Hague, The Netherlands., Buracchi C; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., de Sá Bacelar T; Department of Pediatrics, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Te Marvelde JG; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Trinquand A; Université Paris Descartes-Sorbonne Paris Cité, Institut Necker-Enfants-Malades, INSERM UMR1151, Paris, France., Asnafi V; Université Paris Descartes-Sorbonne Paris Cité, Institut Necker-Enfants-Malades, INSERM UMR1151, Paris, France., Szczepanski T; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia (SUM), Katowice, Poland., Matarraz S; Cancer Research Center (IBMCC-CSIC), Department of Medicine and Cytometry Service, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain., Lopez A; Cancer Research Center (IBMCC-CSIC), Department of Medicine and Cytometry Service, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain., Vidriales B; Hematology Service, University Hospital of Salamanca, Salamanca, Spain., Bulsa J; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia (SUM), Katowice, Poland., Hrusak O; CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic., Kalina T; CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic., Lecrevisse Q; Cancer Research Center (IBMCC-CSIC), Department of Medicine and Cytometry Service, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain., Martin Ayuso M; Cytognos SL, Salamanca, Spain., Brüggemann M; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Verde J; Cytognos SL, Salamanca, Spain., Fernandez P; Institute for Laboratory Medicin, Kantonsspital Aarau AG, Aarau, Switzerland., Burgos L; Clinica Universidad de Navarra-Centro De Investigaciones Medicas Aplicadas (CIMA), University of Navarra, Pamplona, Spain., Paiva B; Clinica Universidad de Navarra-Centro De Investigaciones Medicas Aplicadas (CIMA), University of Navarra, Pamplona, Spain., Pedreira CE; COPPE-Computation Engineering & Systems Post-graduation, Federal University of Rio de Janeiro, Rio de Janeiro(UFRJ), Brazil., van Dongen JJM; Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center, Leiden, The Netherlands., Orfao A; Cancer Research Center (IBMCC-CSIC), Department of Medicine and Cytometry Service, University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: Leukemia [Leukemia] 2018 Apr; Vol. 32 (4), pp. 874-881. Date of Electronic Publication: 2017 Nov 01.

Quality assessment program for EuroFlow protocols: summary results of four-year (2010-2013) quality assurance rounds.

Autor: Kalina T; CLIP - Childhood Leukemia Investigation Prague and Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic., Flores-Montero J, Lecrevisse Q, Pedreira CE, van der Velden VH, Novakova M, Mejstrikova E, Hrusak O, Böttcher S, Karsch D, Sędek Ł, Trinquand A, Boeckx N, Caetano J, Asnafi V, Lucio P, Lima M, Helena Santos A, Bonaccorso P, van der Sluijs-Gelling AJ, Langerak AW, Martin-Ayuso M, Szczepański T, van Dongen JJ, Orfao A

Publikováno v: Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2015 Feb; Vol. 87 (2), pp. 145-56. Date of Electronic Publication: 2014 Oct 23.